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Introduction 
The prevalence of communication 
disorders in individuals with Human 
Immunodeficiency Virus/Acquired Immuno-
deficiency Syndrome (HIV/AIDS) and how 
it compares to the general population are 
unknown.  Treatment advances are being 
made both for individuals with 
communication disorders and those with 
HIV/AIDS.  Unfortunately, little work has 
been done for those who have HIV/AIDS 
and a communication disorder.  Commun-
ication disorders may have a significant 
impact on an individual as speech, language, 
and hearing often are critical to success in 
contemporary life.  Approximately one in 
six Americans has some form of 
communication disorder.1   
The natural history of HIV infection in a 
typical person without antiretroviral therapy 
from the time of HIV transmission to death 
is 10-11 years.2  The initial event is the acute 
retroviral syndrome accompanied by a 
decline in CD4 cell counts.  CD4 cell count 
decreases are due to HIV-induced cell death.  
Late stage disease is characterized by a CD4  
count less than 200 cells/mm3 and 
development of opportunistic infections, 
selected tumors, wasting, and neurologic 
complications. However, progress treating 
HIV infection has decreased mortality rates 
and essentially made the disease a chronic 
condition that can be managed long term.3 
The prevalence rate of HIV infection 
among adults and adolescents was estimated 
at 137.0 per 100,000 at the end of 2005.4 
The prevalence of AIDS also has increased 
steadily  since 2001.    The long-term effects  
 
of HIV/AIDS and its treatment on 
communication abilities raise many 
questions that have not been answered 
adequately.  
 
HIV Infection and the Central Nervous 
System 
HIV enters the central nervous system 
(CNS) early in the course of infection and its 
effect is widespread.  Up to 100% of HIV-
infected adults have CNS abnormalities.5  
Prolonging life in an immunosuppressed 
state has resulted in increased incidence of 
systemic pathologies,  including those of the  
central nervous system.  If the infection 
progresses, various CNS pathologies appear, 
including opportunistic infections, primary 
CNS lymphoma, progressive multifocal 
leukoencephalopathy, peripheral or sensory 
neuropathy, and HIV dementia.3  Primary 
infection of the central nervous system 
occurs when there is a direct infection by 
HIV.  Secondary CNS complications may 
occur due to HIV-associated systemic 
disorders.  Secondary infection occurs when 
HIV infects another system in the body 
through an opportunistic infection, 
neoplasm, or systemic disorder. 
 
Cognitive and Speech-Language Disorders 
Cognitive impairment is one 
manifestation of the CNS complications 
associated with HIV/AIDS.  Cognitive 
changes may be seen early in the course of 
the infection even in patients who are 
otherwise asymptomatic.3,5-6 Common 
cognitive changes include problems with 
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abstract reasoning, learning difficulties, slow 
information processing, and retardation of 
the spontaneity of speech. CNS 
complications in patients with HIV can 
reflect the consequences of medical 
treatment.  Clinicians should distinguish to 
the best of their knowledge between 
symptoms related to the HIV disease process 
and the side effects of antiretroviral 
medications.3 
HIV dementia is seen in approximately 
3% of patients.2  Although a decrease in 
incidence has been reported with 
antiretroviral therapy, the prevalence has 
increased because of patients surviving 
longer.7  Slowed processing speed may 
underlie patient complaints related to 
specific cognitive deficits.6  Psychomotor 
slowness is associated with severity of HIV 
disease and occurs in the context of other 
HIV-related neuropsychiatric symptoms.  
Speech-language symptoms are related to 
memory loss and cognitive slowing.2 
Language difficulties actually may be a 
manifestation of deficits in simple reaction 
time rather than language function.8 
Primary CNS lymphomas are associated 
with the Epstein-Barr virus.2  The incidence 
is less than 6%.  Several symptoms relate to 
speech-language abilities including 
confusion, memory loss, and aphasia.  
Progressive multifocal leukoencephalopathy 
occurs in 1 to 2% of AIDS patients.2 
Cognitive impairments and speech deficits 
related to hemiparesis are common 
symptoms.  Further, up to 9% of AIDS 
patients are referred for psychiatric 
evaluations.2-3 Psychiatric illness may be 
associated with disorganized thinking and 
cognitive changes. 
 
Auditory System Disorders 
The etiologies of auditory system 
disorders in adults with HIV/AIDS fall into 
one of three broad categories: HIV/AIDS as 
the primary cause, opportunistic infections 
associated with HIV/AIDS, and iatrogenic 
sources.   Karposi’s sarcoma, for example, is 
the most common neoplasm in persons with 
HIV/AIDS.5  It is manifested on the pinna 
almost exclusively in persons with 
HIV/AIDS and may cause conductive 
hearing loss when manifested in the ear 
canal, eardrum, or middle ear.9  HIV 
infection also may damage the cochlea, 
eighth nerve, or both, sometimes resulting in 
sensorineural hearing loss; and it also may 
compromise neural pathways and centers in 
the brain resulting in central auditory 
disturbance.5,10 
Opportunistic infections due to 
suppressed immune systems in adults with 
HIV/AIDS can precipitate or exacerbate 
auditory disorders.  These opportunistic 
infections include otitis media or mastoiditis 
in the middle ear,11 neurosyphilis,11-13 cyto-
megalovirus,14 cryptococcal meningitis,11,15 
non-Hodgkin’s lymphoma in the oral 
cavity,5 pharyngeal infections associated 
with hemophilia-A,16 and several other 
infections of the head and neck.10,17-18  
Adults with HIV/AIDS may show head, 
neck and otologic symptoms from 
opportunistic infections, including otalgia, 
otorrhea, tinnitus, “muffled” hearing, aural 
fullness, facial nerve palsy, vertigo and 
central vestibular, and ocular-motor 
disturbance.5,10-11,17-25   
Ototoxicity from drugs used to treat 
adults with HIV/AIDS is the most common 
iatrogenic source of auditory disorders.  
Tseng and colleagues26 found that 17% of 
HIV/AIDS patients who received 
azithromycin experienced drug-related 
hearing problems and three-fourths of these 
problems resolved after azithromycin was 
discontinued.  Kohan and colleagues20 
reported on seven patients with HIV/AIDS 
who had persistent sensorineural hearing 
losses.  Three patients had been exposed 
repeatedly to strong ototoxic drugs (i.e., 
aminoglycosides), while the other four had 
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persistent hearing losses despite standard 
antibiotic treatments.  Simdon and 
colleagues27 reported three cases of auditory 
dysfunction, possibly associated with 
nucleoside analog reverse transcriptase 
inhibitors.  All three patients had histories of 
noise-induced hearing loss and tinnitus that 
worsened during antiretroviral therapy.  
Marra and colleagues11 also reported that 
hearing loss was associated with 
antiretroviral therapy in subjects with 
HIV/AIDS, particularly subjects 35 years or 
older.  
Whatever the etiology, some middle ear 
infections in adults with HIV/AIDS, such as 
chronic otitis media, supporative otitis 
media, and mastoiditis, are as common as 
those in adults without HIV/AIDS and often 
respond to medical treatment as well.10,22  
Conversely, pneumocystis carinii otitis 
media is an opportunistic infection unique to 
persons with HIV disease and can cause 
conductive or mixed hearing losses.5,10 
Sensorineural hearing loss, which often 
cannot be treated medically, is more 
common among adults with than those 
without HIV/AIDS.10,18,20,28  The likelihood 
of sensorineural hearing loss among adults 
with HIV/AIDS varies among studies 
depending on the characteristics of the 
sample and the criteria for hearing loss.  In 
general, sensorineural hearing losses 
occurred in one-third to two-thirds of the 
subjects.  They usually occurred more at 
high frequencies than at low frequencies and 
were more severe in patients with more 
severe HIV infections17 or, similarly, with 
greater deterioration in immunologic 
status28.  Furthermore, most neuro-otological 
disorders in HIV/AIDS patients have a 
central origin; both central auditory 
disorders and peripheral auditory disorders 
are more common in advanced stages of 
HIV/AIDS.21,29-30  Central auditory disorders 
also may be more common in adults with 
HIV-Associated Dementia31, though 
research in this area is lacking.   Finally, 
common risk factors for hearing loss in 
adults in general (e.g., excessive noise 
exposure or aging) can impact the 
prevalence and severity of auditory 
problems in adults with HIV/AIDS. 
 
Audiological Testing 
Although HIV/AIDS can manifest 
problems at all levels of the auditory system, 
a limited variety of audiologic tests have 
been used to measure auditory function in 
the HIV/AIDS population.  Clearly, the most 
common measure has been auditory evoked 
potentials, an EEG type of test in which the 
presence of brainwaves are recorded to 
predominantly non-speech sounds.  
Although a small number of researchers 
have recorded evoked responses from the 
upper brainstem, thalamus, and cortex,32-33 
most have used auditory brainstem response 
(ABR) testing which measures neural 
responses mainly from the eighth nerve and 
lower and mid brainstem.10,25,31,34-43  The 
emphasis on ABR testing may arise from its 
ability to detect early clinical and sub-
clinical pathologic changes in the eighth 
nerve and brainstem of adults with 
HIV/AIDS.34-36,43  Larson5 advocated that 
the evaluation of hearing loss in the patient 
with AIDS should be approached as an 
eighth nerve neuropathy.  She suggested that 
audiologists complete a test battery 
including pure tone testing, speech 
audiometry, tympanometry, acoustic reflex 
testing, and ABR testing. 
Larson’s proposed auditory test battery 
is more extensive than most researchers 
have used in studies of audition in patients 
with HIV/AIDS.5 Nevertheless, by focusing 
on measuring eighth nerve neuropathology, 
Larson’s battery may not be comprehensive 
enough to track the variety of auditory 
problems encountered with HIV/AIDS in 
adults.  Her battery did not include any 
measures of social-emotional manifestations 
Kansas Journal of Medicine 2008                                                                                     Communication Disorders 
 
 65 
of hearing loss, which may be even more 
prominent when it accompanies HIV/AIDS.  
One popular valid measure of social and 
emotional problems that has been used with 
adults without HIV/AIDS is the Hearing 
Handicap Inventory for Adults.44 If Larson 
proposed her battery today, moreover, it 
likely would include otoacoustic emissions 
testing.  This is an electro-acoustic measure 
of the cochlea’s outer hair cell function 
which can be compromised by ototoxic 
drugs.45 
The most prominent omissions in 
Larson’s battery are behavioral auditory 
tests of central auditory processing.  Recent 
professional guidelines of the American-
Speech-Language-Hearing Association46 
mandate that behavioral measures are 
essential for diagnosing central auditory 
processing disorders; conversely, they 
cannot be diagnosed by electrophysiological 
measures alone.   
The most widely researched behavioral 
test battery of central auditory processing 
disorders in adults was developed over 
several decades by an audiologist, James 
Jerger, and his colleagues.47-55  It employs 
performance-intensity functions for both 
monosyllabic words, performance-intensity 
functions for scrambled sentences presented 
to the same ear in noise (i.e., Synthetic 
Sentence Identification for ipsilateral 
competing messages or SSI-ICM), and 
scrambled sentences presented 
simultaneously in both ears (i.e., dichotic 
sentence identification or DSI).  This battery 
can differentiate auditory disorders between 
the cochlea, eighth nerve, brainstem, and 
temporal lobe.  This battery contains the 
essential elements in any successful central 
auditory test battery, efficient and effective 
controls over cochlear sensitivity loss, 
absolute speech recognition ability, and non-
auditory influences.54   
The SSI-ICM and DSI have been used to 
diagnose central auditory processing 
disorders in subjects with varying degrees of 
brain damage.56 To our knowledge, 
however, a case study of an adult with AIDS 
and organic brain disease was the only study 
of these measures in a subject with 
HIV/AIDS.30 The patient showed 
abnormally reduced scores on in both ears 
on the SSI-ICM. 
As radiographic technology, such as 
magnetic resonance imaging, has improved 
over the past two decades, many audiology 
facilities serving adults no longer routinely 
use relatively expensive ABR testing for 
diagnosing space-occupying lesions.  
Conversely, nearly all audiology clinics in 
the United States have personnel, 
equipment, and materials to complete pure 
tone testing, speech audiometry, 
tympanometry, acoustic reflex testing, 
otoacoustic emissions testing, and the 
Hearing Handicap Inventory for Adults.  In 
other words, nearly all audiologists have the 
capability to evaluate, in about two hours, 
both peripheral and central auditory function 
of adults with HIV/AIDS.  Such a feasible, 
yet comprehensive, test battery may become 
more vital for tracking auditory problems of 
adults with HIV/AIDS as they live longer 
and grow in numbers.  No researchers, 
however, have studied such a 
comprehensive test battery in HIV/AIDS 
patients systematically.   
 
Summary 
Speech, language, and hearing disorders 
are not uncommon in individuals with 
HIV/AIDS.  Little research, however, has 
explored the relationship and impact 
between HIV/AIDS and communication 
abilities.  Several factors related to 
HIV/AIDS influence communication 
abilities.  These factors include CNS 
abnormalities related to the infection, 
opportunistic infection, and treatment 
effects.  Clinicians should distinguish to the 
best of their knowledge between symptoms 
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related to the HIV disease process and the 
side effects of antiretroviral medications.  
Assessments of communication disorders 
should be obtained as necessary to provide 
quality care to individuals with HIV/AIDS 
and to maintain the quality of life that 
effective communication provides. 
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